SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001818382-23-000050
Filing Date
2023-06-15
Accepted
2023-06-15 16:23:56
Documents
1
Group Members
AYABUDGE LLC BRADY W DOUGAN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A humaschedule13d_a3.htm SC 13D/A 113596
  Complete submission text file 0001818382-23-000050.txt   114989
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Subject) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91701 | Film No.: 231017684
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 35 WILSHIRE ROAD GREENWICH CT 06831
Business Address
Niklason Laura E (Filed by) CIK: 0001878075 (see all company filings)

Type: SC 13D/A